Cited by 263MicroRNA in disease regulationExtracellular vesicles in diseasePancreatic function and diabetes

Role of microRNAs in diabetes and its cardiovascular complications

Open access
Shantikumar, S., Caporali, A., Emanueli, C.·2012·Cardiovascular Research

Abstract

Diabetes is the most common metabolic disorder and is recognized as one of the most important health threats of our time. MicroRNAs (miRNAs) are a novel group of non-coding small RNAs that have been implicated in a variety of physiological processes, including glucose homeostasis. Recent research has suggested that miRNAs play a critical role in the pathogenesis of diabetes and its related cardiovascular complications. This review focuses on the aberrant expression of miRNAs in diabetes and examines their role in the pathogenesis of endothelial dysfunction, cardiovascular disease, and diabetic retinopathy. Furthermore, we discuss the potential role of miRNAs as blood biomarkers and examine the potential of therapeutic interventions targeting miRNAs in diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvr300

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • microRNAs may link the metabolic dysregulation seen in prediabetes with vascular dysfunction.

    “microRNAs may also link the metabolic dysregulation seen in prediabetes with vascular dysfunction.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [135]

  • microRNAs can alter the expression of genes in insulin-producing and insulin-sensitive tissues, including the pancreas, liver, and vasculature.

    “microRNAs can alter the expression of genes in insulin-producing and insulin-sensitive tissues, including the pancreas, liver, and vasculature.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [135]

  • Hyperglycemia increases the expression of several microRNAs found in the endothelium, including miR-320, miR-221, miR-503, and miR-125b.

    “Hyperglycemia increases the expression of several microRNAs found in the endothelium, including miR-320, miR-221, miR-503, and miR-125b.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [135]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

3 retracted

Flagged first, then by citations

Research works printed but not linked: 1

  1. [50]White MF Regulating insulin signaling and beta-cell function through IRS proteins Can J Physiol Pharmacol 2006 84 725 737 16998536

Cited by

Sorted by citations

Authors
Shantikumar, S., Caporali, A., & Emanueli, C.
Affiliations
Bristol Royal Infirmary (GB)
Corresponding author
Emanueli, C.
Venue
Cardiovascular Research
Published
2011-11-07
Volume
93
Issue
4
Pages
583-593
ISSN
0008-6363 (ISSN-L)
OpenAlex
W2121271900
Cited by
263
References
129
Citations by year
2026: 7 · 2025: 10 · 2024: 8 · 2023: 13 · 2022: 19 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 30 · 2017: 24 · 2016: 23 · 2015: 21 · 2014: 21 · 2013: 26 · 2012: 13
FWCI
1.39
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Cardiovascular Research (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
  • Explore Bristol Research (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion)
Funders
British Heart Foundation (FS/10/61/28566, FS/10/001/27959)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
microRNA, diabetes mellitus, cardiovascular complications, endothelial dysfunction, diabetic retinopathy, glucose homeostasis, blood biomarkers, miRNA-targeted therapy, diabetic cardiomyopathy
MeSH terms
Animals, Diabetic Angiopathies, Diabetic Retinopathy, Disease Models, Animal, Endothelium, Vascular, Humans, Insulin Resistance, Biomarkers, MicroRNAs, Diabetes Complications, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review